The average one-year price target for Ono Pharmaceutical Co., - Depositary Receipt (OTCPK:OPHLY) (MUN:ON40) has been revised to $5.41 / share. This is an increase of 12.00% from the prior estimate of ...

The average one-year price target for Chugai Pharmaceutical Co., - Depositary Receipt (OTCPK:CHGCY) (MUN:CUP0) has been revised to $26.89 / share. This is a decrease of 15.22% from the prior estimate ...

Simcere Pharmaceutical Group has delivered a strong 3 year share price gain, which puts a spotlight on whether the recent level around HK$11.02 is adequately backed by what the business is earning ...

Sustainable packaging is only the beginning. What a medicine is made from—and how its ingredients are produced—matters just ...

Andreas Eschbach is the founder and CEO of eschbach, a software company that helps production teams work smarter and enhance collaboration. The pharmaceutical industry stands at a critical juncture.

Future-ready pharma manufacturing requires flexible capacity, digital innovation, strong quality systems, integrated value ...

Takeda Pharmaceutical touched $19.45, a fresh 52-week high that clears the September 17 peak by 2.1%. The ADR and the OTC ...

In today’s digitally transformed world, technology plays a critical role in how pharmaceutical companies do business. From drug discovery to manufacturing and commercialization, technology is powering ...

China Resources Pharmaceutical Group has delivered a 46.5% return over the past 5 years, which puts a spotlight on what ...

Pharmaceutical scientists conduct vital research that leads to new medicines and therapeutic treatments, helping to improve the lives of patients around the world. Their work sits at the intersection ...

A comprehensive review of 167 studies shows that pharmaceutical and clinical effluents are transforming aquatic ecosystems ...

A practical reference for global buyers evaluating active pharmaceutical intermediate suppliers in China. CALIFORNIA, ...